Surgery for Obesity and Related Diseases最新文献

{"title":"Cartoon","authors":"","doi":"10.1016/j.soard.2025.03.002","DOIUrl":"10.1016/j.soard.2025.03.002","url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"21 5","pages":"Page 618"},"PeriodicalIF":3.5,"publicationDate":"2025-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143683572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"SOARD Category 1 CME Credit Featured Articles, Volume 21, May 2025","authors":"","doi":"10.1016/j.soard.2025.03.001","DOIUrl":"10.1016/j.soard.2025.03.001","url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"21 5","pages":"Pages 615-617"},"PeriodicalIF":3.5,"publicationDate":"2025-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143683573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"SOARD Category 1 CME Credit Featured Articles, Volume 21, April 2025","authors":"","doi":"10.1016/j.soard.2025.02.006","DOIUrl":"10.1016/j.soard.2025.02.006","url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"21 4","pages":"Pages 518-520"},"PeriodicalIF":3.5,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143552157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cartoon","authors":"","doi":"10.1016/j.soard.2025.02.005","DOIUrl":"10.1016/j.soard.2025.02.005","url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"21 4","pages":"Page 521"},"PeriodicalIF":3.5,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143552156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"SOARD Category 1 CME Credit Featured Articles, Volume 21, March 2025","authors":"","doi":"10.1016/j.soard.2025.01.001","DOIUrl":"10.1016/j.soard.2025.01.001","url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"21 3","pages":"Pages 341-343"},"PeriodicalIF":3.5,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143294870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cartoon","authors":"","doi":"10.1016/j.soard.2025.01.006","DOIUrl":"10.1016/j.soard.2025.01.006","url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"21 3","pages":"Page 344"},"PeriodicalIF":3.5,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143294869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluation of gastric content in fasting patient during semaglutide use: an observational study","authors":"Veronica Neves Fialho Queiroz M.D., Ph.D. ,&nbsp;Priscila Mina Falsarella M.D., Ph.D. ,&nbsp;Renato Carneiro de Freitas Chaves M.D., Ph.D. ,&nbsp;Miguel Jose Francisco Neto M.D., Ph.D. ,&nbsp;João Manoel Silva Jr. M.D., Ph.D. ,&nbsp;Guilherme Freitas Araújo M.D. ,&nbsp;Flávio Takaoka M.D., Ph.D. ,&nbsp;Flávia Julie do Amaral Pfeilsticker M.D., Ms.C. ,&nbsp;Guilherme Falleiros Mendes M.D. ,&nbsp;Rodrigo Gobbo Garcia M.D., Ph.D.","doi":"10.1016/j.soard.2024.08.039","DOIUrl":"10.1016/j.soard.2024.08.039","url":null,"abstract":"<div><h3>Background</h3><div>The evident influence of GLP-1 agonists as semaglutide on gastric emptying even in adherence to recommended fasting protocols instigates debates.</div></div><div><h3>Objective</h3><div>To investigate the effect of semaglutide on gastric content by gastric ultrasonography in volunteers.</div></div><div><h3>Setting</h3><div>Private hospital.</div></div><div><h3>Methods</h3><div>The present study is an observational, cross-sectional, and single-center study. We included 30 consecutive volunteers aged ≥18 years who had undergone a minimum fasting period of 8 hours for solid foods and 2 hours for clear, residue-free liquids. The intervention group consisted of 15 volunteers who had used semaglutide within the last 7 days, whereas the control group consisted of 15 volunteers who had never used semaglutide. The main objective was to determine whether the stomach was full or not.</div></div><div><h3>Results</h3><div>Between June 2023 and August 2023, a total of 30 adult volunteers were included in the study, and no participant was excluded. The semaglutide group exhibited a higher prevalence of full stomach (11 of 15 [73%] versus 1 of 15 [7%], <em>P</em> &lt; .001; adjusted to age <em>P</em> = .003). The semaglutide group also exhibited a higher prevalence of early satiety (10 of 15 [67%] versus 0 of 15 [0%], <em>P</em> &lt; .001), loss of appetite (10 of 15 [67%] versus 0 of 15 [0%], <em>P</em> &lt; .001), gastric fullness (8 of 15 [53%] versus 0 of 15 [0%], <em>P</em> = .002), and nausea (7 of 15 [47%] versus 1 of 15 [7%], <em>P</em> = .035). Additionally, there is no case in the semaglutide group with no gastric contents.</div></div><div><h3>Conclusions</h3><div>The use of semaglutide is associated with full stomach even after appropriate overnight fasting. Semaglutide is also associated with increased gastrointestinal symptoms such as loss of appetite, early satiety, gastric fullness, and nausea.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"21 2","pages":"Pages 146-151"},"PeriodicalIF":3.5,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142335540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Statin use trajectories postbariatric surgery: a matched cohort analysis","authors":"Anyull D. Bohorquez Caballero M.D. ,&nbsp;Elizabeth Wall-Wieler Ph.D. ,&nbsp;Yuki Liu M.Sc. ,&nbsp;Feibi Zheng M.D. ,&nbsp;Michael A. Edwards M.D.","doi":"10.1016/j.soard.2024.08.043","DOIUrl":"10.1016/j.soard.2024.08.043","url":null,"abstract":"<div><h3>Background</h3><div>Metabolic and bariatric surgery (MBS) is the most durable treatment of obesity and can reduce statin use.</div></div><div><h3>Objective</h3><div>We compare statin use trajectories in patients with and without MBS.</div></div><div><h3>Methods</h3><div>Adults with a body mass index ≥ 35kg/m² were identified using a U.S. employer-based retrospective claims database. Individuals who had MBS were matched 1:1 with those who did not. Trajectories of statin use were stratified by statin use in the year before the index date and examined in the 2 years after the index date.</div></div><div><h3>Setting</h3><div>University Hospital.</div></div><div><h3>Results</h3><div>Sixteen thousand three hundred fifty-nine adults who had MBS and 16,359 matched adults who did not were analyzed. In both groups, 19.4% filled a statin prescription in the year before the index date. In the 2 years after the index date, individuals using statins remained similar at 20% (year 1) and 19% (year 2) among those who didn’t have an MBS and decreased to 12.5% (year 1) and 9.3% (year 2) in the MBS cohort. Among baseline statin users, 35.4% of non-MBS and 60.4% of the MBS cohort stopped using statins within 2 years of the index date. Among statin naïve individuals at baseline, 9.6% of the non-MBS cohort started using statins within 2 years of the index date, compared to 2.6% of those who had MBS.</div></div><div><h3>Conclusions</h3><div>MBS results in a significant discontinuation of statins among baseline users, and significantly decreased the initiation of medications among individuals who were statin naive at baseline. This demonstrates that MBS is both a treatment and preventative measure for dyslipidemia.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"21 2","pages":"Pages 152-157"},"PeriodicalIF":3.5,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142396452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Patients experience with preoperative use of anti-obesity medications and associations with bariatric surgery expectations","authors":"Jason M. Samuels M.D. ,&nbsp;Mayur B. Patel M.D., M.P.H., F.A.C.S. ,&nbsp;Christianne L. Roumie M.D., M.P.H. ,&nbsp;Wesley Self M.D., M.P.H. ,&nbsp;Luke Funk M.D., M.P.H. ,&nbsp;Matthew D. Spann M.D., M.M.H.C. ,&nbsp;Kevin D. Niswender M.D., Ph.D.","doi":"10.1016/j.soard.2024.08.041","DOIUrl":"10.1016/j.soard.2024.08.041","url":null,"abstract":"<div><h3>Background</h3><div>Few studies have investigated the use of anti-obesity medications (AOMs) before bariatric surgery and how prior use impacts patients’ goals and expectations for surgery.</div></div><div><h3>Objectives</h3><div>This study investigated associations between patients’ experiences with AOMs and weight loss expectations before bariatric surgery.</div></div><div><h3>Settings</h3><div>Single tertiary university hospital.</div></div><div><h3>Methods</h3><div>Patients were electronically surveyed with a 31-item questionnaire via email or the patient portal with a primary predictor variable of AOMs presurgery. Outcomes included degree of weight loss and weight regain and motivation for seeking surgery.</div></div><div><h3>Results</h3><div>A total of 346 persons were invited to complete the survey; 112 surveys (32.4%) were completed, with 7 excluded because of not answering the AOM question. 73% reported AOM use. Among those who took AOMs before seeking bariatric surgery, average weight loss was 13 kg (SD 10) corresponding to a 4.4-kg/m² decrease in BMI. Of past AOM recipients, 87% reported weight regain on stopping AOMs. Average weight regain was 18 kg (SD 13; 126% increase). Patients reported improved longevity and quality of life as motivation for seeking surgery, with AOM use history having no effect. Subjects reported an average weight loss goal of 65.8 kg (39% of baseline weight) from bariatric surgery.</div></div><div><h3>Conclusions</h3><div>AOMs were commonly used in those seeking bariatric surgery, but motivation for surgery did not differ by AOM use history. Motivations were most often related to goals for better overall health.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"21 2","pages":"Pages 109-114"},"PeriodicalIF":3.5,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142402541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evolution of treated obstructive sleep apneas syndrome after bariatric surgery: an observational retrospective study","authors":"Corentin Puech M.D. ,&nbsp;Jérémie Thereaux M.D., Ph.D. ,&nbsp;Francis Couturaud M.D., Ph.D. ,&nbsp;Christophe Leroyer M.D., Ph.D. ,&nbsp;Cécile Tromeur M.D., Ph.D. ,&nbsp;Christophe Gut-Gobert M.D. ,&nbsp;Charles Orione M.D. ,&nbsp;Raphaël Le Mao M.D., Ph.D. ,&nbsp;Cécile L’hévéder M.D.","doi":"10.1016/j.soard.2024.08.038","DOIUrl":"10.1016/j.soard.2024.08.038","url":null,"abstract":"<div><h3>Background</h3><div>The resolution of obstructive sleep apneas syndrome (OSAS) following bariatric surgery appears to be promising for the majority of patients although this resolution does not necessarily exhibit a linear correlation with weight loss. Previous small-scale studies have pinpointed a younger age and preoperative weight under 100kg as predictive factors of OSAS improvement</div></div><div><h3>Objectives</h3><div>The primary objective was to evaluate the evolution of OSAS in patients treated with continuous positive airway pressure (CPAP). Additionally, we tried to identify potential predictive factors for OSAS improvement postsurgery.</div></div><div><h3>Setting</h3><div>Brest Hospital, France, University Hospital.</div></div><div><h3>Methods</h3><div>In this retrospective, observational study we analyzed a cohort of 44 patients who underwent bariatric surgery, between January 2015 and December 2021. Each patient underwent respiratory polygraphy (RP) or polysomnography (PSG) before and after the surgical procedure. We collected CPAP data (including effective pressure and adherence) before and during the 6 months following the intervention.</div></div><div><h3>Results</h3><div>Within the study population, 68.18% of patients exhibited improved OSAS, as defined as an apnea-hypopnea index of less than 15 per hour. A higher mean oxygen saturation prior to surgery emerged as the sole predictive factor for OSAS improvement. CPAP adherence and therapeutic pressure value, 2 rarely studied parameters, did not show significant difference between improved and nonimproved patients.</div></div><div><h3>Conclusions</h3><div>The rate of OSAS resolution after surgery is 68.18%, with only a higher mean oxygen saturation before surgery identified as a predictive factor for OSAS resolution.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"21 2","pages":"Pages 127-134"},"PeriodicalIF":3.5,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142378758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}